Travere Therapeutics
The Executive Director, R&D Strategy & Operations serves as the strategic partner and Chief of Staff to the EVP, Head of R&D & Chief Medical Officer, driving organizational effectiveness and operational excellence across the R&D organization. This leadership role partners with the R&D Leadership Team to translate strategic priorities into coordinated execution, manage organizational risks, and facilitate cross-functional collaboration. The position provides enterprise-wide visibility into organizational priorities, portfolio strategy, and resource allocation to support informed executive decision-making.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago